12.06.2012
- On May 11, 2012 Jean-Pierre Clamadieu succeeded Christian Jourquin as CEO of the Solvay group, since the consolidation of Rhodia in last year's third quarter one of Europe's...
31.05.2012
- We are delighted to present you with this supplement for the ACHEMA 2012. On the next eight pages, we invite you to discover a one-of-a-kind reference, our leading resource, the...
18.05.2012
- International drugmakers are working with European authorities on emergency plans to keep medicines flowing into Greece if the country crashes out of the euro. Discussions have...
14.05.2012
- The 2008-2009 crisis signaled the start of a paradigm shift in chemical plant engineering and construction. Traditional EPC (engineering, procurement and construction) suppliers...
09.05.2012
- India's main drug regulator has not been properly scrutinizing some drugs before approving them, and some of its officials are colluding with drug firms and medical experts to...
03.05.2012
- Airgas posted a better-than-expected quarterly profit, hiked its dividend 25%, and named a new chief executive so its founder can focus more on growth projects, all bullish signs...
26.04.2012
- Johnson & Johnson is sending in a former Army Ranger to clean up several big messes that have hurt its reputation, earnings and share price in the past three years. Alex Gorsky...
25.04.2012
- German industrial conglomerate Evonik may put its planned second-quarter listing on ice if valuations in the chemical sector remain at current levels, two sources close to the...
24.04.2012
- Watson Pharmaceuticals aims to announce an agreement to buy Actavis for around $6 billion on Wednesday, April 25th, in a deal making it one of the world's biggest suppliers of...
20.04.2012
- European regulators have endorsed the continued use of Novartis's multiple sclerosis pill Gilenya, one of the Swiss firm's top new drug hopes, but said on Friday the drug needed to...
